News And Features

Pneumonia Features

VIEW ALL

COVID-19 Effective Strategies for Vaccine Communication

By Elisabeth Blair

Pneumonia News

VIEW ALL

Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13

After 2010, all invasive pneumococcal infection serotypes were those not included in 13-valent pneumococcal conjugate vaccine.

Survey Reveals HCP Challenges With Pneumococcal Vaccine Recommendations

Findings from this survey were presented at the October 2022 ACIP meeting.

Investigational 21-Valent Pneumococcal Conjugate Vaccine Immunogenic, Safe

V116 is an investigational 21-valent pneumococcal conjugate vaccine.

First-in-Class Anti-Infective Agent Granted Fast Track Status for Severe CABP

CAL02 is a first-in-class non-biological, broad-spectrum, bacterial virulence neutralizer.

More Clinical Events Occur in COVID-19 Pneumonia vs Other Viral Pneumonias

Investigators compared thrombotic and clinical trends, death rates, and patient characteristics for SARS-CoV-2 viral pneumonia vs H3N2/H1N1 viral pneumonia.